Pure Biologics Spólka Akcyjna
PUR.WA · WSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | PLN 88 | PLN 40 | PLN 51 | PLN 173 |
| - Cash | PLN 0 | PLN 4 | PLN 2 | PLN 6 |
| + Debt | PLN 14 | PLN 13 | PLN 3 | PLN 3 |
| Enterprise Value | PLN 102 | PLN 50 | PLN 52 | PLN 170 |
| Revenue | PLN 0 | PLN 0 | PLN 1 | PLN 0 |
| % Growth | -100% | -85.6% | 160.6% | – |
| Gross Profit | -PLN 0 | -PLN 3 | -PLN 5 | -PLN 4 |
| % Margin | – | -2,709.5% | -816.8% | -1,585.4% |
| EBITDA | -PLN 12 | -PLN 26 | -PLN 23 | -PLN 9 |
| % Margin | – | -27,449.5% | -3,440.6% | -3,392.9% |
| Net Income | -PLN 19 | -PLN 36 | -PLN 26 | -PLN 13 |
| % Margin | – | -37,572.6% | -3,983.7% | -5,146.1% |
| EPS Diluted | -3.78 | -11.19 | -11.87 | -5.88 |
| % Growth | 66.2% | 5.7% | -101.9% | – |
| Operating Cash Flow | -PLN 11 | -PLN 23 | -PLN 17 | -PLN 24 |
| Capital Expenditures | PLN 0 | -PLN 0 | -PLN 6 | -PLN 1 |
| Free Cash Flow | -PLN 11 | -PLN 23 | -PLN 23 | -PLN 25 |